Say "yes" to methadone and buprenorphine in Russian Federation

Heroin Addiction and Related Clinical Problems

Volumn 8, Issue 2, 2006, Pages 5-22

  Maremmani, Icro ^a   Pacini, Matteo ^b   Pani, Pier Paolo ^c   Parrino, Mark ^d  

^a European Opiate Addiction Treatment Association EUROPAD

^b EUROPAD Italia ^*

^c Italian Society of Addiction Medicine SITD   (Italy)

^d American Association for the Treatment of Opioid Dependence AATOD   (United States)

Author keywords

Buprenorphine treatment; Heroin Addiction; Medically Assisted Rehabilitation; Methadone treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; DOSE RESPONSE; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERANCE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; MEDICAL SOCIETY; METHADONE TREATMENT; MORTALITY; NARCOTIC DEPENDENCE; OPIATE ADDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RUSSIAN FEDERATION; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

EID: 33746266836     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. AA. VV (2005): Medication-Assisted Treatment for Opioid Addiction. TIP Series 43. DHHS Pubblication N° (SMA) 05-4048. SAMHSA, Rockville, ML.
2. APPEL P. W., JOSEPH H., RICHMAN B. L. (2000): Causes and rates of death among methadone maintenance patients before and after the onset of the HIV/AIDS epidemic. Mount Sinai Journal of Medicine. 67:(5-6) 444-451.
3. BALL J., Ross A. (1991): Follow-up study of 105 patients who left treatment. In: BALL J. C., Ross A. (Eds.): The Effectiveness of Methadone Maintenance Treatment. Springer-Verlag, New York. pp.
4. BERGER H. (1973): Prevention of the diversion of clinic methadone to the street market. Proc Natl Conf Methadone Treat. 2 1264-1266.
5. BERGER H. (1977): Heroin maintenance. Br J Addict Alcohol Other Drugs. 72:(3) 269-273.
6. BOSCH X. (2001): Spain authorises clinical trial on heroin maintenance therapy. Lancet. 357:(9265) 1347.
7. BOURNE P. G. (1973): Methadone diversion. Proc Natl Conf Methadone Treat. 2 839-841.
8. CHARLAND L. C. (2003): Heroin addicts and consent to heroin therapy: a comment on Hall et al. (2003). Addiction. 98:(11) 1634-1635.
9. CICERO T. J., INCIARDI J. A. (2005): Diversion and abuse of methadone prescribed for pain management. Jama. 293:(3) 297-298.
10. DAWE S., GRAY J. (1995): Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts. Drug and Alcohol Dependence. 39 207-212.
11. DOLE V. P. (1972): Comments on "heroin maintenance". Jama. 220:(11) 1493.
12. DOLE V. P. (1972): Narcotic addiction, physical dependence and relapse. New England Journal of Medicine. 286 988-992.
13. DOLE V. P. (1980): Addictive behaviour. Scientific American. 243 138-154.
14. DOLE V. P. (1988): Implications of methadone maintenance for theories of narcotic addiction. JAMA. 260 3025-3029.
15. DOLE V. P., JOSEPH H. (1978): Long term outcome of patients treated with methadone maintenance. Annals of the New York Academy of Sciences. 311 181-189.
16. DOLE V. P., NYSWANDER M. E. (1965): A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrocloride. JAMA. 193 80-84.
17. DOLE V. P., NYSWANDER M. E. (1967): Heroin Addiction: A Metabolic Disease. Archives of Internal Medicine. 120 19-24.
18. DOLE V. P., NYSWANDER M. E. (1968): Methadone maintenance and its implication for theories of narcotic addiction. In: WIKLER A. (Ed.) The Addictive State. Williams and Wilkins, Baltimore, pp. 359-366.
19. DOLE V. P., NYSWANDER M. E., KREEK M. J. (1966): Narcotic Blockade. Archives of Internal Medicine. 118 304-309.
20. DOLE V. P., NYSWANDER M. E., WARNER A. (1968): Successful treatment of 750 criminal addicts. JAMA. 206 2708-2711.
21. FERRI M., DAVOLI M., PERUCCI C. A. (2003): Heroin maintenance for chronic heroin dependents. Cochrane Database Syst Rev:(3) CD003410.
22. FERRI M., DAVOLI M., PERUCCI C. A. (2005): Heroin maintenance for chronic heroin dependents. Cochrane Database Syst Rev:(2) CD003410.
23. FINK M. (1972): Heroin maintenance. Jama. 221:(6) 602.
24. GEARING F. R., SCHWEITZER M. D. (1974): An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. American Journal of Epidemiology. 100 101-112.
25. GLATT M. M. (1972): Heroin maintenance? Int Pharmacopsychiatry. 7:(1-4) 61-63.
26. GOLDMAN F. R., THISTEL C. I. (1978): Diversion of methadone: illicit methadone use among applicants to two metropolitan drug abuse programs. Int J Addict. 13:(6) 855-862.
27. HOLLY G. (2004): Canada: coroner's inquest into the methadone-related death of a prisoner. Can HIV AIDS Policy Law Rev. 9:(1) 49.
28. JOHNSON R., JAFFE J., FUDALA P. (1992): A controlled comparative trial of buprenorphine and methadone treatment for opioid dependence. JAMA. 267 2750-2755.
29. JOHNSON R. E., CHUTUAPE M. A., STRAIN E. C., WALSH S. L., STITZER M. L., BIGELOW G. E. (2000): A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine. 343:(18) 1290-1297.
30. JOHNSON R. E., EISSENBERG T., STITZER M. L., STRAIN E. C., LIEBSON I. A., BIGELOW G. E. (1995): Buprenorphine treatment of opioid dependence: clinical trial of daily vs. alternate-day dosing. Drug and Alcohol Dependence. 40:(1) 27-35.
31. JOHNSON R. E., JAFFE J. H., FUDALA P. J. (1992): A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 267 2750-2755.
32. JOHNSON R. E., JONES H. E., FISCHER G. (2003): Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 70:(2 Suppl) S87-S101.
33. KORAN L. M. (1973): Heroin maintenance for heroin addicts: issues and evidence. N Engl J Med. 288:(13) 654-660.
34. KREEK M. J., ZHON Y., SCHUSSMAN S. (2004): Craving in Opiate, Cocaine and Alcohol Addiction. Heroin Add & Rel Clin Probl. 6:(2-3) 5-52.
35. KUO I. I., FISCHER B., VLAHOV D. (2000): Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. Int J Drug Policy. 11:(5) 357-370.
36. LEAVITT S. B., SHINDERMAN M., MAXWELL S., EAP C. B., PARIS P. (2000): When "enough" is not enough: new perspectives on optimal methadone maintenance dose. Mt Sinai J Med. 67:(5-6) 404-411.
37. LEWIS E., JR. (1973): A heroin maintenance program in the United States? Jama. 223:(5) 539-546.
38. LIDZ C. W. (1975): Heroin maintenance and heroin control. Int J Addict. 10:(1) 35-52.
39. LOGAN D. G. (1973): Heroin maintenance clinics: does the "British System" have answers for U.S. addiction treatment shortcomings? Proc Natl Conf Methadone Treat. 1 579-585.
40. LOGAN D. G. (1974): Heroin maintenance clinics. A discussion of the U.S. addiction treatment and the "British System". Ohio State Med J. 70:(3) 165-169.
41. LUBRANO S., PACINI M., GIUNTOLI G., MAREMMANI I. (2002): Is craving for heroin and alcohol related to low methadone dosages in methadone maintened patients. Heroin Add & Rel Clin Probl. 4:(2) 11-17.
42. MAREMMANI I., BALESTRI C., SBRANA A., TAGLIAMONTE A. (2003): Substance(ab)use during methadone and naltrexone treatment. Interest of adequate methadone dosage. Journal of Maintenance in the Addictions. 2:(1-2) 19-36.
43. MAREMMANI I., SHINDERMAN M. S. (1999): Alcohol, benzodiazepines and other drugs use in heroin addicts treated with methadone. Polyabuse or undermedication? Heroin Add & Rel Clin Probl. 1:(2) 7-13.
44. MAREMMANI I., ZOLESI O., DAINI L., CAPONE M. R., AGLIETTI M., CASTROGIOVANNI P. (1995): Pharmacotherapy for craving. In: TAGLIAMONTE A., MAREMMANI I. (Eds.): Drug Addiction and Related Clinical Problems. Springer-Verlag, Vienna, New York. pp. 51-56.
45. MCCARTY F. (1974): Editorial: A case for heroin maintenance. Clin Toxicol. 7:(3) 337-342.
46. No AUTHORS LISTED (1973): The "British system" of heroin maintenance. Jama. 224:(3) 397-399.
47. OSTINI R., BAMMER G., DANCE P. R., GOODIN R. E. (1993): The ethics of experimental heroin maintenance. J Med Ethics. 19:(3) 175-182.
48. PACINI M., MAREMMANI I. (2005): Medical meaning of psychosocial issues of heroin addiction. Heroin Add & Rel Clin Probl. 7:(2) 37-48.
49. PACINI M., MELLINI A., ATTILIA M. L., CECCANTI M., MAREMMANI I. (2005): Alcohol abuse in heroin addicts: An unfolding metabolic destiny. Heroin Add & Rel Clin Probl. 7:(1) 31-38.
50. PAYTE T. J. (2004): Methadone Treatment. Safe induction techniques. Heroin Add & Rel Clin Probl. 6:(1) 35-42.
51. PERNEGER T. V., GINER F., DEL Rio M., MINO A. (1998): Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. Bmj. 317:(7150) 13-18.
52. PERNEGER T. V., GINER F., DEL RIO M., MINO A. (1998): Severely addicted heroin users benefit from heroin maintenance programme. Bmj. 317:(7150) A.
53. PEYSER P. A. (1973): Heroin maintenance clinics. N Engl J Med. 289:(4) 222.
54. PILLARD R. C. (1973): Shall we allow heroin maintenance? N Engl J Med. 288:(13) 682-683.
55. PIRNAY S., BORRON S. W., GIUDICELLI C. P., TOURNEAU J., BAUD F. J., RICORDEL I. (2004): A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction. 99:(8) 978-988.
56. RESNICK R. B. (1977): Problems of methadone diversion and implications for control. Int J Addict. 12:(7) 803-806.
57. RITTER A., DI NATALE R. (2005): The relationship between take-away methadone policies and methadone diversion. Drug Alcohol Rev. 24:(4) 347-352.
58. ROOM R. (2002): Heroin maintenance and attraction to treatment. Eur J Public Health. 12:(3) 234-235.
59. SHAH N., LATHROP S. L., LANDEN M. G. (2005): Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998-2002. Addiction. 100:(2) 176-188.
60. STATON M., LEUKEFELD C. (2002): Heroin maintenance and the United States. Subst Use Misuse. 37:(4) 549-554.
61. STRAIN E. C., BIGELOW G. E., LIEBSON I. A., STITZER M. L. (1999): Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Jama. 281:(11) 1000-1005.
62. TAGLIAMONTE A. (1999): Heroin Addiction as normal illness. Heroin Add & Rel Clin Probl. 1:(1) 9-12.
63. TAGLIAMONTE A., MAREMMANI I. (2001): The problem of drug dependence. Heroin Add & Rel Clin Probl. 3:(2) 7-20.
64. VORMFELDE S. V., POSER W. (2001): Death attributed to methadone. Pharmacopsychiatry. 34:(6) 217-222.
65. WAGNER-SERVAIS D., ERKENS M. (2003): Methadone-Related Deaths Associated with Faulty Induction Procedures. J Maint Addict. 2:(3) 57-67.
66. ZADOR D., SUNJIC S. (2000): Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995. Addiction. 95:(1) 77-84.
67. ZADOR D. A., SUNJIC S. D. (2002): Methadone-related deaths and mortality rate during induction into methadone maintenance, New South Wales, 1996. Drug Alcohol Rev. 21:(2) 131-136.
68. ZOLESI O., DAINI L., CAPONE M. R., AGLIETTI M., RAIMONDI F., MAREMMANI I. (1995): The use of GHB in anticraving therapy. Preliminary Experimental Data of its Use in Alcohol and Heroin Dependence. In: TAGLIAMONTE A., MAREMMANI I. (Eds.): Drug Addiction and Related Clinical Problems. Springer-Verlag, Vienna, New York. pp. 57-62.
69. ZWEBEN J. E., PAYTE J. T. (1990): Methadone maintenance in the treatment of opioid dependance: A current perspective. The West Journ of Med. 152(T) 588-599.